![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 41, 38797-38802, October 11, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Structural Biology and
The x-ray structure of the unactivated kinase
domain of insulin-like growth factor-1 receptor (IGFRK-0P) is reported
here at 2.7 Å resolution. IGFRK-0P is composed of two lobes connected by a hinge region. The N-terminal lobe of the kinase is a twisted
Crystal Structure of the Apo, Unactivated Insulin-like Growth
Factor-1 Receptor Kinase
IMPLICATION FOR INHIBITOR SPECIFICITY*
,
Department of Cancer Research, Merck Research
Laboratories, West Point, Pennsylvania 19486
-sheet flanked by a single helix, and the C-terminal lobe comprises eight
-helices and four short
-strands. The ATP binding pocket and the catalytic center reside at the interface of the two lobes. Despite the overall similarity to other receptor tyrosine kinases, three notable conformational modifications are observed: 1) this kinase
adopts a more closed structure, with its two lobes rotated further
toward each other; 2) the conformation of the proximal end of the
activation loop (residues 1121-1129) is different; 3) the orientation
of the nucleotide-binding loop is altered. Collectively, these
alterations lead to a different ATP-binding pocket that might impact on
inhibitor designs for IGFRK-0P. Two molecules of IGFRK-0P are seen in
the asymmetric unit; they are associated as a dimer with their ATP
binding clefts facing each other. The ordered N terminus of one monomer
approaches the active site of the other, suggesting that the
juxtamembrane region of one molecule could come into close proximity to
the active site of the other.
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
C. Schalk-Hihi, H.-C. Ma, G. T. Struble, S. Bayoumy, R. Williams, E. Devine, I. P. Petrounia, T. Mezzasalma, L. Zeng, C. Schubert, et al. Protein Engineering of the Colony-stimulating Factor-1 Receptor Kinase Domain for Structural Studies J. Biol. Chem., February 9, 2007; 282(6): 4085 - 4093. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Li and W. T. Miller Role of the Activation Loop Tyrosines in Regulation of the Insulin-like Growth Factor I Receptor-tyrosine Kinase J. Biol. Chem., August 18, 2006; 281(33): 23785 - 23791. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Blanquart, N. Boute, D. Lacasa, and T. Issad Monitoring the Activation State of the Insulin-Like Growth Factor-1 Receptor and Its Interaction with Protein Tyrosine Phosphatase 1B Using Bioluminescence Resonance Energy Transfer Mol. Pharmacol., September 1, 2005; 68(3): 885 - 894. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Li, N. D. Covino, E. G. Stein, J. H. Till, and S. R. Hubbard Structural and Biochemical Evidence for an Autoinhibitory Role for Tyrosine 984 in the Juxtamembrane Region of the Insulin Receptor J. Biol. Chem., July 3, 2003; 278(28): 26007 - 26014. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |